Stock 6657 ENERGENESIS BIOMEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Energenesis Biomedical CO.,LTD.

Equities

6657

TW0006657000

Biotechnology & Medical Research

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
55 TWD +0.36% Intraday chart for Energenesis Biomedical CO.,LTD. +2.61% -8.94%
Apr. 08 Energenesis Biomedical CO.,LTD. announced a financing transaction CI
Feb. 29 Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

ENERGENESIS BIOMEDICAL CO., LTD. is mainly engaged in the research and development of new drugs. The Company's main product projects include experimental service analysis and reagent sales. The Company's main new drugs include ENERGI-F703, ENERGI-F701, ENERGI-F711, and ENERGI-F706. The ENERGI-F703 indications are diabetic foot ulcers. The ENERGI-F701 indications are abnormal alopecia. The ENERGI-F711 indications are burns. The ENERGI-F706 indications are cachexia.

Number of employees: 35

Sales per Business

TWD in Million2022Weight2023Weight Delta
Reagents
53.3 %
3 39.8 % 4 53.3 % +30.18%
Service
46.7 %
4 60.2 % 3 46.7 % -24.36%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
7 100.0 % 7 100.0 % -2.63%

Managers

Managers TitleAgeSince
Han Min Chen FOU
 Founder - 12-08-27
Pei Chao Chen DFI
 Director of Finance/CFO - 20-05-24
Yi-fang Cheng CTO
 Chief Tech/Sci/R&D Officer - 13-07-31
Chun-fang Huang CTO
 Chief Tech/Sci/R&D Officer - 20-04-30
Ming Tsan Chiang IRC
 Investor Relations Contact - 16-07-31
Chun Tsai Lin IRO
 Public Communications Contact - -
Mei Fang Chen AUD
 Comptroller/Controller/Auditor - 21-12-16
Li Min Chen PRN
 Corporate Officer/Principal - 15-02-28

Members of the board

Members of the board TitleAgeSince
Shou Shan Wu BRD
 Director/Board Member 74 19-05-05
Jen Yi Chiu FOU
 Founder - 12-08-27
Han Min Chen FOU
 Founder - 12-08-27
Chun Tsai Lin IRO
 Public Communications Contact - -
Chung Jung Tsai BRD
 Director/Board Member - 16-10-04
Ko Hua Ting BRD
 Director/Board Member - 19-05-05
Yue Jen Wu BRD
 Director/Board Member - 19-10-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,063,000 51,892,000 ( 68.22 %) 0 68.22 %

Company contact information

Energenesis Biomedical Co., Ltd.

6/F-3 21, Lane 583, Ruiguang Road

114694, Taipei

+

http://www.energenesis-biomedical.com
address Energenesis Biomedical CO.,LTD.(6657)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ENERGENESIS BIOMEDICAL CO.,LTD. Stock Energenesis Biomedical CO.,LTD.
-8.94% 128M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.77% 42.86B
LONZA GROUP AG Stock Lonza Group AG
+44.64% 41.36B
MODERNA, INC. Stock Moderna, Inc.
+12.24% 42.74B
CELLTRION, INC. Stock Celltrion, Inc.
-8.83% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.44% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.01% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.56% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.82% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.35% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6657 Stock
  4. Company Energenesis Biomedical CO.,LTD.